HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibacterial therapy of neurosyphilis: lack of impact of new therapies.

Abstract
Neurosyphilis is caused by the spirochete Treponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen that favours compliance. Penicillin was first introduced for the treatment of syphilis in 1943, and despite interest in the use of amoxicillin, erythromycin, tetracycline, doxycycline, ceftriaxone and azithromycin, penicillin remains the only recommended antibacterial agent for neurosyphilis.
AuthorsLatisha Ali, Karen L Roos
JournalCNS drugs (CNS Drugs) Vol. 16 Issue 12 Pg. 799-802 ( 2002) ISSN: 1172-7047 [Print] New Zealand
PMID12421113 (Publication Type: Journal Article, Review)
Chemical References
  • Antitreponemal Agents
  • Penicillins
Topics
  • Antitreponemal Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Humans
  • Neurosyphilis (cerebrospinal fluid, drug therapy)
  • Penicillins (administration & dosage, pharmacokinetics, therapeutic use)
  • Treatment Outcome
  • Treponema pallidum (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: